Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana

Abstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected...

Full description

Bibliographic Details
Main Authors: Edem Kojo Dzantor, Mubarick Nungbaso Asumah, Abdul‐Wahab Inusah, Nimota Ruth Nukpezah, Yaa Nyarko Agyeman, Margaret Wekem Kukeba, Baba Abubakari Braimah, Theophilus Adjeso, Mohammed Mutaru Tahiru
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Nursing Open
Subjects:
Online Access:https://doi.org/10.1002/nop2.1438
_version_ 1811166932455391232
author Edem Kojo Dzantor
Mubarick Nungbaso Asumah
Abdul‐Wahab Inusah
Nimota Ruth Nukpezah
Yaa Nyarko Agyeman
Margaret Wekem Kukeba
Baba Abubakari Braimah
Theophilus Adjeso
Mohammed Mutaru Tahiru
author_facet Edem Kojo Dzantor
Mubarick Nungbaso Asumah
Abdul‐Wahab Inusah
Nimota Ruth Nukpezah
Yaa Nyarko Agyeman
Margaret Wekem Kukeba
Baba Abubakari Braimah
Theophilus Adjeso
Mohammed Mutaru Tahiru
author_sort Edem Kojo Dzantor
collection DOAJ
description Abstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25. Results The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self‐reported prevalence of SARS‐CoV‐2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self‐reported SARS‐CoV‐2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health‐targeted interventions to boost public confidence in SARS‐CoV‐2 vaccines.
first_indexed 2024-04-10T16:01:41Z
format Article
id doaj.art-a23ac9788af545fe90065582ea170c09
institution Directory Open Access Journal
issn 2054-1058
language English
last_indexed 2024-04-10T16:01:41Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Nursing Open
spelling doaj.art-a23ac9788af545fe90065582ea170c092023-02-10T12:27:02ZengWileyNursing Open2054-10582023-03-011031785179310.1002/nop2.1438Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of GhanaEdem Kojo Dzantor0Mubarick Nungbaso Asumah1Abdul‐Wahab Inusah2Nimota Ruth Nukpezah3Yaa Nyarko Agyeman4Margaret Wekem Kukeba5Baba Abubakari Braimah6Theophilus Adjeso7Mohammed Mutaru Tahiru8Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health University of Health and Allied Sciences Hohoe GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Preventive Nursing School of Nursing and Midwifery, University for Development Studies Tamale GhanaDepartment of Population and Reproductive Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Nursing School of Nursing and Midwifery, CKT‐University of Technology and Applied Sciences Navrongo GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Ear Nose and Throat, School of Medicine University for Development Studies Tamale GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaAbstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25. Results The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self‐reported prevalence of SARS‐CoV‐2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self‐reported SARS‐CoV‐2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health‐targeted interventions to boost public confidence in SARS‐CoV‐2 vaccines.https://doi.org/10.1002/nop2.1438adverse eventsfirst dosehealthcare workersSARS‐CoV‐2vaccine
spellingShingle Edem Kojo Dzantor
Mubarick Nungbaso Asumah
Abdul‐Wahab Inusah
Nimota Ruth Nukpezah
Yaa Nyarko Agyeman
Margaret Wekem Kukeba
Baba Abubakari Braimah
Theophilus Adjeso
Mohammed Mutaru Tahiru
Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
Nursing Open
adverse events
first dose
healthcare workers
SARS‐CoV‐2
vaccine
title Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
title_full Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
title_fullStr Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
title_full_unstemmed Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
title_short Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
title_sort adverse events reported after first dose of sars cov 2 vaccine in the northern region of ghana
topic adverse events
first dose
healthcare workers
SARS‐CoV‐2
vaccine
url https://doi.org/10.1002/nop2.1438
work_keys_str_mv AT edemkojodzantor adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT mubaricknungbasoasumah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT abdulwahabinusah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT nimotaruthnukpezah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT yaanyarkoagyeman adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT margaretwekemkukeba adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT babaabubakaribraimah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT theophilusadjeso adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana
AT mohammedmutarutahiru adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana